Pyridostigmine and Its Effects on Autonomic Modulation in Diabetic Patients

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine if pyridostigmine bromide improves heart rate variability of type 2 diabetes mellitus subjects with cardiovascular autonomic neuropathy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital de Clinicas de Porto Alegre
• Treatments: Pyridostigmine Bromide

Criteria

Inclusion Criteria:

• diabetes mellitus

Exclusion Criteria:

• myocardial infarction

• acute ischemic syndromes

• second or third degree atrioventricular block

• active alcoholism

• thyroid dysfunction

• chronic obstructive pulmonary disease

• history of intolerance to pyridostigmine.